HeyJaredTyler Bundy
- Indexed articles, last 90 days
- 8
- Latest publication
- Sep 16, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Aug 11, 2026
Latest articles
Bank of America sees 21% upside in this beverage stock (opens the original)
Read excerpt
A major beverage company is preparing for one of the biggest changes in its history after acquiring JDE Peet's and setting the stage to divide its beverage and coffee operations. Bank of America thinks that split could give investors a better look at what the company's individual businesses are worth. The bank reiterated its Buy rating and $38 price objective on Keurig Dr Pepper (KDP), representing 21.1% upside from the $31.39 price used in its Sept. 14 report, in a note given to TheStreet. BofA
Bank of America sees more upside in restaurant stock (opens the original)
Read excerpt
One sandwich chain is still early in its life as a public company, and Bank of America already sees reasons for investors to get more bullish. The chain's latest results showed improving customer traffic alongside continued expansion, giving Wall Street another look at the growth story following its July debut. The momentum has Bank of America looking past some near-term expense pressure and focusing on what it sees as a stronger long-term setup. Jersey Mike's Subs (JMKE) reported second-quarter
Bank of America makes bullish call on gas stock (opens the original)
Read excerpt
Casey's General Stores has spent much of the last few years building a business that looks increasingly different from the traditional gas station. Pizza, prepared food, and a growing rewards program have helped make the convenience retailer a destination even when customers are not filling up. The company operates nearly 3,000 stores across 19 states and has roughly 11 million Casey's Rewards members. That momentum did not spare the stock after its latest earnings report. Casey's General Stores
Bank of America sees major upside in this biotech stock (opens the original)
Read excerpt
Alvotech has spent years building a biosimilar platform that Wall Street has struggled to value through regulatory delays, manufacturing investment, and uneven commercial results. Bank of America now thinks the investment case is entering a different phase, one that could leave substantial upside for shareholders if the company executes. The bank initiated coverage of Alvotech (ALVO) with a Buy rating and a $7 price objective, implying roughly 58% upside from the $4.43 reference price in its Aug
Bank of America sends message on Capital One stock (opens the original)
Read excerpt
Capital One Financial has spent more than a year integrating Discover while investors watch whether the massive acquisition can translate into faster growth and stronger returns. The latest monthly data gave Wall Street a mixed picture. Capital One (COF) posted healthy credit trends in July, but growth in its domestic card portfolio slowed from the prior month. Bank of America is still sticking with the stock. In a note given to TheStreet, BofA analyst Mihir Bhatia maintained a Buy rating and a
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.